Search Press releases Keywords From To 27 Feb 2013 UCB in 2012: New Core Medicines Drive Growth Read More 26 Feb 2013 UCB to license worldwide rights to tozadenant in Parkinson’s disease from Biotie Therapies Read More 21 Feb 2013 UCB and ConfometRx announce new R&D partnership Read More 20 Feb 2013 UCB announces regulatory filings for Cimzia® (certolizumab pegol) to treat psoriatic arthritis and axial spondyloarthritis Read More 11 Feb 2013 Acceleration of Fracture Healing with CDP7851/AMG785 will not move into phase 3 Read More 5 Feb 2013 UCB: Accelerating focus on the patient Read More Pagination First page Previous page Previous … Page 116 Page 117 Page 118 Page 119 Current page 120 Page 121 Page 122 Page 123 Page 124 … Next page Next Last page Stay up-to-date on the latest news and information from UCB Subscribe
